201 related articles for article (PubMed ID: 7738959)
1. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis.
Worthley SG; McNeil JD
J Rheumatol; 1995 Feb; 22(2):335-7. PubMed ID: 7738959
[TBL] [Abstract][Full Text] [Related]
2. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
[TBL] [Abstract][Full Text] [Related]
3. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
4. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
5. High dose intravenous methotrexate for refractory rheumatoid arthritis.
Shiroky JB; Neville C; Skelton JD
J Rheumatol; 1992 Feb; 19(2):247-51. PubMed ID: 1629823
[TBL] [Abstract][Full Text] [Related]
6. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
[TBL] [Abstract][Full Text] [Related]
7. Acute leukemia after low dose methotrexate therapy in a patient with rheumatoid arthritis.
Pointud P; Prudat M; Peron JM
J Rheumatol; 1993 Jul; 20(7):1215-6. PubMed ID: 8371222
[TBL] [Abstract][Full Text] [Related]
8. Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis.
Halla JT; Hardin JG
J Rheumatol; 1994 Jul; 21(7):1224-6. PubMed ID: 7966062
[TBL] [Abstract][Full Text] [Related]
9. Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review.
Kingsmore SF; Hall BD; Allen NB; Rice JR; Caldwell DS
J Rheumatol; 1992 Sep; 19(9):1462-5. PubMed ID: 1433017
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
[TBL] [Abstract][Full Text] [Related]
11. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
12. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
[TBL] [Abstract][Full Text] [Related]
13. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate.
Ellman MH; Hurwitz H; Thomas C; Kozloff M
J Rheumatol; 1991 Nov; 18(11):1741-3. PubMed ID: 1787499
[TBL] [Abstract][Full Text] [Related]
14. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.
Gabriel S; Creagan E; O'Fallon WM; Jaquith J; Bunch T
J Rheumatol; 1990 Apr; 17(4):460-5. PubMed ID: 2348423
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
[TBL] [Abstract][Full Text] [Related]
17. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
Hamilton SF; Campbell NR; Kara M; Watson J; Connors M
J Rheumatol; 2003 Sep; 30(9):1948-50. PubMed ID: 12966595
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
20. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Basin KS; Escalante A; Beardmore TD
J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
